JP2021185139A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021185139A5 JP2021185139A5 JP2021123899A JP2021123899A JP2021185139A5 JP 2021185139 A5 JP2021185139 A5 JP 2021185139A5 JP 2021123899 A JP2021123899 A JP 2021123899A JP 2021123899 A JP2021123899 A JP 2021123899A JP 2021185139 A5 JP2021185139 A5 JP 2021185139A5
- Authority
- JP
- Japan
- Prior art keywords
- peo
- pharmaceutical composition
- release
- composition according
- million
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 25
- 239000008194 pharmaceutical composition Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 8
- 238000009472 formulation Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 239000004033 plastic Substances 0.000 claims description 3
- 229920003023 plastic Polymers 0.000 claims description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical group [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 2
- 229910052782 aluminium Inorganic materials 0.000 claims description 2
- 239000003086 colorant Substances 0.000 claims description 2
- 239000011888 foil Substances 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 238000013268 sustained release Methods 0.000 claims description 2
- 239000012730 sustained-release form Substances 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims 2
- 229920001223 polyethylene glycol Polymers 0.000 claims 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000007922 dissolution test Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- PBAPPPCECJKMCM-IBGZPJMESA-N mirabegron Chemical compound S1C(N)=NC(CC(=O)NC=2C=CC(CCNC[C@H](O)C=3C=CC=CC=3)=CC=2)=C1 PBAPPPCECJKMCM-IBGZPJMESA-N 0.000 description 2
- 229960001551 mirabegron Drugs 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020170033944A KR102051132B1 (ko) | 2017-03-17 | 2017-03-17 | 미라베그론 또는 이의 염을 포함하는 방출조절용 약제학적 조성물 |
| KR10-2017-0033944 | 2017-03-17 | ||
| JP2019548680A JP2020510679A (ja) | 2017-03-17 | 2018-03-15 | ミラベグロンまたはその塩を含む放出調節用薬剤学的組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019548680A Division JP2020510679A (ja) | 2017-03-17 | 2018-03-15 | ミラベグロンまたはその塩を含む放出調節用薬剤学的組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021185139A JP2021185139A (ja) | 2021-12-09 |
| JP2021185139A5 true JP2021185139A5 (enrdf_load_stackoverflow) | 2022-03-29 |
Family
ID=63522330
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019548680A Pending JP2020510679A (ja) | 2017-03-17 | 2018-03-15 | ミラベグロンまたはその塩を含む放出調節用薬剤学的組成物 |
| JP2021123899A Pending JP2021185139A (ja) | 2017-03-17 | 2021-07-29 | ミラベグロンまたはその塩を含む放出調節用薬剤学的組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019548680A Pending JP2020510679A (ja) | 2017-03-17 | 2018-03-15 | ミラベグロンまたはその塩を含む放出調節用薬剤学的組成物 |
Country Status (4)
| Country | Link |
|---|---|
| JP (2) | JP2020510679A (enrdf_load_stackoverflow) |
| KR (1) | KR102051132B1 (enrdf_load_stackoverflow) |
| CN (1) | CN110446490B (enrdf_load_stackoverflow) |
| WO (1) | WO2018169325A1 (enrdf_load_stackoverflow) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021069944A1 (en) * | 2019-10-09 | 2021-04-15 | Alvogen Korea Co., Ltd. | Pharmaceutical composition comprising mirabegron and process for manufacturing the same |
| KR102546923B1 (ko) | 2020-03-03 | 2023-06-26 | 동광제약 주식회사 | 미라베그론을 포함하는 제어 방출 제제 |
| WO2023022520A1 (ko) * | 2021-08-18 | 2023-02-23 | 주식회사 삼양홀딩스 | 룩소리티닙의 경구용 정제 조성물 및 이의 제조 방법 |
| EP4338729A1 (en) | 2022-09-19 | 2024-03-20 | Sanovel Ilac Sanayi Ve Ticaret A.S. | A tablet comprising mirabegron |
| KR20240102908A (ko) * | 2022-12-26 | 2024-07-03 | 주식회사 렉스팜텍 | 아픽사반을 포함하는 서방성 정제 |
| EP4410279A1 (en) | 2023-01-25 | 2024-08-07 | Sanovel Ilac Sanayi Ve Ticaret A.S. | A film tablet comprising mirabegron |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA99407B (en) * | 1998-01-22 | 1999-07-20 | Abbott Lab | Extended release tiagabine formulations with reduced side-effects. |
| RU2321401C2 (ru) * | 2002-11-07 | 2008-04-10 | Астеллас Фарма Инк. | Лекарственное средство против гиперактивного мочевого пузыря, включающее производное анилида уксусной кислоты в качестве активного ингредиента |
| CA2550866A1 (en) * | 2003-12-23 | 2005-07-14 | Alza Corporation | Methods and dosage forms for increasing solubility of drug compositions for controlled delivery |
| SA07280459B1 (ar) * | 2006-08-25 | 2011-07-20 | بيورديو فارما إل. بي. | أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني |
| TWI478712B (zh) * | 2008-09-30 | 2015-04-01 | Astellas Pharma Inc | 釋控性醫藥組成物 |
| WO2011122523A1 (ja) * | 2010-03-29 | 2011-10-06 | アステラス製薬株式会社 | 放出制御医薬組成物 |
| JPWO2013147134A1 (ja) * | 2012-03-30 | 2015-12-14 | アステラス製薬株式会社 | ミラベグロン含有医薬組成物 |
| KR20150045500A (ko) * | 2012-08-31 | 2015-04-28 | 아스텔라스세이야쿠 가부시키가이샤 | 경구 투여용 의약 조성물 |
| CN104288116A (zh) * | 2014-09-05 | 2015-01-21 | 南京华威医药科技开发有限公司 | 一种米拉贝隆缓释片组合物 |
| KR20170088783A (ko) * | 2017-07-07 | 2017-08-02 | 지엘팜텍주식회사 | 미라베그론의 습식과립 조성물 |
| EP3292864A1 (en) * | 2017-10-12 | 2018-03-14 | Synthon B.V. | Modified release tablet composition comprising mirabegron |
-
2017
- 2017-03-17 KR KR1020170033944A patent/KR102051132B1/ko active Active
-
2018
- 2018-03-15 JP JP2019548680A patent/JP2020510679A/ja active Pending
- 2018-03-15 WO PCT/KR2018/003043 patent/WO2018169325A1/ko active Application Filing
- 2018-03-15 CN CN201880018616.8A patent/CN110446490B/zh not_active Expired - Fee Related
-
2021
- 2021-07-29 JP JP2021123899A patent/JP2021185139A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021185139A5 (enrdf_load_stackoverflow) | ||
| WO2014154029A1 (zh) | 复合骨架材料及其药物组合物 | |
| JP2021185139A (ja) | ミラベグロンまたはその塩を含む放出調節用薬剤学的組成物 | |
| JP2017536404A (ja) | 胃保持性の徐放性懸濁組成物 | |
| RU2004137118A (ru) | Фармацевтическая композиция для контролируемого высвобождения активных веществ и способ ее изготовления | |
| WO2009069139A1 (en) | Dosage form providing an ibuprofen-containing liquid fill | |
| JP5421063B2 (ja) | ジクロフェナクナトリウム含有水性貼付剤 | |
| CA2926424C (en) | Aprepitant oral liquid formulations | |
| JP6768070B2 (ja) | 粘膜付着性医薬組成物及びその製造方法 | |
| JP2019500416A (ja) | デュタステリド及びプロピレングリコールモノラウレートを含有する医薬組成物及びその調製方法 | |
| JP2013505233A5 (enrdf_load_stackoverflow) | ||
| Hirpara et al. | Optimization & screening of different film forming polymers and plasticizers in fast dissolving sublingual film | |
| EA033893B1 (ru) | Лекарственная форма в виде пленки, содержащей свободное основание тадалафила и полимер на основе полиэтиленгликоля и/или полимер на основе винилпирролидона в качестве агента, стабилизирующего дисперсию, раствор для получения пленки и способ получения пленки | |
| WO2014192918A1 (ja) | 口腔貼付剤 | |
| BR102013032405A2 (pt) | Composição farmacêutica na forma de uma suspensão oral compreendendo uma fração de flavonoide e uma goma de xantano | |
| Sumi et al. | Effective development and evaluation of oral thin film of etoricoxib | |
| TW201143812A (en) | Aqueous composition to be contained in container | |
| ES2444591T3 (es) | Medicamento con el principio activo hidromorfona con estabilidad al almacenamiento mejorada | |
| JP5200365B2 (ja) | 粘膜適用液剤 | |
| Siripruekpong et al. | Development and Evaluation of floating In situ gel for oral delivery of propranolol HCl | |
| AU2014284294A1 (en) | Capsule formulation comprising fexofenadine | |
| WO2015101639A1 (en) | Orodispersible film | |
| KR20070056119A (ko) | 점막 또는 피부 의약 또는 위생 시스템 | |
| JP2017506647A (ja) | 爪真菌症を治療するための局所用抗真菌薬組成物 | |
| CN116531401A (zh) | 一种包含匹可硫酸钠、活性氧化镁、枸橼酸的药物组合物 |